Lurasidone hydrochloride
CAS No. 367514-88-3
Lurasidone hydrochloride ( —— )
Catalog No. M14263 CAS No. 367514-88-3
Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 32 | In Stock |
|
10MG | 51 | In Stock |
|
25MG | 66 | In Stock |
|
50MG | 87 | In Stock |
|
100MG | 132 | In Stock |
|
200MG | 213 | In Stock |
|
500MG | 447 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLurasidone hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma.
-
DescriptionLurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT1A; 5-HT2A; 5-HT7; D2; Norepinephrine α2C
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number367514-88-3
-
Formula Weight529.14
-
Molecular FormulaC28H36N4O2S·HCl
-
Purity>98%(HPLC)
-
SolubilityDMSO: 1 mg/mL (1.88 mM)
-
SMILESC1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Murai T, et al. Behav Brain Res. 2014 Mar 15;261:26-30.
molnova catalog
related products
-
Targocil
Targocil is used as a bacteriostatic inhibitor of wall teichoic acid (WTA) biosynthesis which can inhibit the growth of methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (MIC90s: 2 μg/ mL) for both MRSA and MSSA.
-
AVN-101
A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM).
-
Ziprasidone hydrochl...
A full antagonist of D2 and 5-HT2A receptors with Ki of 6.8 and 0.6 nM, respectively; also is a partial agonist of 5-HT1A, and a partial antagonist of 5-HT2C and 5-HT1D receptors.